相关实验视频

Updated: May 30, 2025

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

第一次干预对心脏参数的影响:一项系统性审查

Kevin A Huynh^1,2,3, Jin Al-Gully^1,2,4, José M Montero-Cabezas⁴

¹Division of Endocrinology, Department of Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

European journal of endocrinology

|January 29, 2025

概括

降低生长激素的治疗可以改善心脏结构和功能,在壮病患者. 实现生化缓解对于更好的心脏结果和预防进一步的心脏病进展至关重要.

科学领域:

内分泌学在内分泌学.
心脏病学心脏病学
系统审查是系统的审查.

背景情况:

巨症是一种生长激素过多的情况,显著增加了心血管疾病的风险,这是导致死亡的主要原因.
心脏表现包括左心室缩和功能障碍,有助于发病率和死亡率.

研究的目的:

系统地审查第一个增长激素降低干预措施对壮症患者心脏参数的影响.
为了评估心脏结构和功能在初级治疗方式后的变化.

主要方法:

在2022年2月之前发表的26项研究 (17个队列,9个病例报告) 的系统审查.
包括主要治疗:手术和体静止素受体连接剂.
评估心脏结构 (LVH,LVM/LVMi) 和功能 (LVEF,E/A比率).
用修改的纽卡斯尔-太华尺度和JBI检查清单评估偏差风险.

主要成果:

大多数研究表明,干预后心脏结构和功能有所改善.
观察到左心室质量 (9/15项研究) 和LVH患病率 (3/13项研究) 显著下降.
在LVEF (9/14研究) 和E/A比率 (6/7研究) 中发现显著增加.
心脏结构在实现生化缓解的患者中得到了更大的改善.

结论:

医疗和手术治疗都能改善与壮症相关的心脏变化.
正常化或降低生长激素/IGF-1水平是预防心脏病进展和不良结果的关键.

关键词:

亚克罗梅加利症是什么心脏功能是指心脏功能.心肌病性心脏病 - 心肌病性心脏病左心室缩症是指左心室缩症.索马托斯塔丁类型的类似物通过形外科手术.

更多相关视频

A Closed-chest Model to Induce Transverse Aortic Constriction in Mice

A Closed-chest Model to Induce Transverse Aortic Constriction in Mice

Published on: April 5, 2018

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy

Published on: October 6, 2022

相关概念视频

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...